RA and PsA patients must demonstrate a 50% reduction in tender and swollen joints and a 20% reduction in ESR or CRP levels at 3 months and continue to demonstrate such a response every 6 months in order to continue on biological treatment. Here, CRP is linked to rheumatoid arthritis.